onychomycosis - Articles and news items

Moberg begins patient enrolment in US and Europe Phase 3 onychomycosis trials

Industry news / 28 September 2016 / Niamh Louise Marriott, Digital Content Producer

Approximately 10% of the general population suffer from onychomycosis and a majority of those afflicted go untreated. The prescription market is growing…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+